41 results
8-K
EX-10.1
ouo671pxoo4jx
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
z1ow8i
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-10.1
8im7it th5v3ig
20 Mar 20
Immune Therapeutics, Inc. to Collaborate with Cytocom, Inc. to Develop Therapies for COVID-19
11:43am
DRS/A
hjegcyve
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
llgi4 rvx16ssq3
14 Oct 16
IPO registration
12:00am